ES2135351A1 - Derivados de 5-aroilnaftaleno. - Google Patents
Derivados de 5-aroilnaftaleno.Info
- Publication number
- ES2135351A1 ES2135351A1 ES09800141A ES9800141A ES2135351A1 ES 2135351 A1 ES2135351 A1 ES 2135351A1 ES 09800141 A ES09800141 A ES 09800141A ES 9800141 A ES9800141 A ES 9800141A ES 2135351 A1 ES2135351 A1 ES 2135351A1
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- hydrogen
- acyl
- halogenalkyl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/67—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Luminescent Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Derivados de 5-aroilnaftaleno. La invención se refiere a compuestos de fórmula (I), en donde A, Z, R1, R2, y R3 tienen el significado expresado en la memoria y en las reivindicaciones. La invención se refiere también a composiciones farmacéuticas que contienen a los productos antes mencionados, a métodos para su empleo y a métodos para la preparación de esos compuestos. Los productos de la invención son inhibidores de prostaglandina G/H sintasa, y se usan como anti-inflamatorios y analgésicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3646697P | 1997-01-28 | 1997-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2135351A1 true ES2135351A1 (es) | 1999-10-16 |
ES2135351B1 ES2135351B1 (es) | 2000-05-16 |
Family
ID=21888759
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98905325T Expired - Lifetime ES2178162T3 (es) | 1997-01-28 | 1998-01-21 | Derivados de 5-aroilnaftaleno. |
ES009800141A Expired - Fee Related ES2135351B1 (es) | 1997-01-28 | 1998-01-27 | Derivados de 5-aroilnaftaleno. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98905325T Expired - Lifetime ES2178162T3 (es) | 1997-01-28 | 1998-01-21 | Derivados de 5-aroilnaftaleno. |
Country Status (38)
Country | Link |
---|---|
US (2) | US5962531A (es) |
EP (1) | EP0966437B1 (es) |
JP (1) | JP3607706B2 (es) |
KR (1) | KR100313180B1 (es) |
CN (1) | CN1159293C (es) |
AR (1) | AR011571A1 (es) |
AT (1) | ATE219051T1 (es) |
AU (1) | AU721407B2 (es) |
BR (1) | BR9807520A (es) |
CA (1) | CA2278687C (es) |
CO (1) | CO4930273A1 (es) |
CZ (1) | CZ259399A3 (es) |
DE (2) | DE69805974T2 (es) |
DK (1) | DK0966437T3 (es) |
ES (2) | ES2178162T3 (es) |
FR (1) | FR2758818B1 (es) |
GB (1) | GB2321457B (es) |
HR (1) | HRP980046A2 (es) |
HU (1) | HUP0001061A3 (es) |
ID (1) | ID22825A (es) |
IL (1) | IL130909A0 (es) |
IT (1) | IT1298159B1 (es) |
MA (1) | MA26469A1 (es) |
NO (1) | NO313136B1 (es) |
NZ (1) | NZ336684A (es) |
PA (1) | PA8444901A1 (es) |
PE (1) | PE51499A1 (es) |
PL (1) | PL334769A1 (es) |
PT (1) | PT966437E (es) |
RU (1) | RU2188192C2 (es) |
SV (1) | SV1998000013A (es) |
TN (1) | TNSN98013A1 (es) |
TR (1) | TR199901783T2 (es) |
TW (1) | TW520355B (es) |
UY (1) | UY24860A1 (es) |
WO (1) | WO1998032732A1 (es) |
YU (1) | YU34499A (es) |
ZA (1) | ZA98495B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001277560A1 (en) | 2000-08-09 | 2002-02-18 | F. Hoffmann-La Roche Ag | Quinolene derivatives as anti-inflammation agents |
MXPA04008104A (es) * | 2002-02-22 | 2006-05-25 | Upjohn Co | Derivados de arilsulfona. |
CN1675154A (zh) * | 2002-06-07 | 2005-09-28 | 科蒂科股份有限公司 | 抑制巨噬细胞移动抑制因子(mif)的细胞因子或生物活性的萘衍生物 |
EP1692101B1 (en) * | 2003-03-31 | 2011-07-06 | Council of Scientific and Industrial Research | Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
DE602004002832T2 (de) | 2003-05-07 | 2007-06-06 | Osteologix A/S | Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen |
JP2009541219A (ja) * | 2006-06-12 | 2009-11-26 | メルク エンド カムパニー インコーポレーテッド | 高眼圧治療のための眼科組成物 |
WO2013086229A1 (en) * | 2011-12-07 | 2013-06-13 | Amgen Inc. | Bicyclic aryl and heteroaryl sodium channel inhibitors |
WO2014201173A1 (en) | 2013-06-12 | 2014-12-18 | Amgen Inc. | Bicyclic sulfonamide compounds as sodium channel inhibitors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH384567A (de) * | 1958-10-17 | 1964-11-30 | Geigy Ag J R | Verfahren zur Herstellung neuer Benzophenonsulfonamide |
US3899529A (en) * | 1973-02-22 | 1975-08-12 | Merck & Co Inc | Aroyl substituted naphthalene acetic acids |
EP0354329A1 (de) * | 1988-07-09 | 1990-02-14 | Bayer Ag | (Hetero)Aryloxynaphthaline mit über Schwefel gebundenen Substituenten |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6816241A (es) * | 1967-12-01 | 1969-06-03 | ||
US3655679A (en) * | 1969-06-25 | 1972-04-11 | Merck & Co Inc | Certain aryl pyridine carboxylic acid derivatives |
US3755455A (en) * | 1970-12-09 | 1973-08-28 | Sandoz Ag | (1-alkoxy-2-naphthyl)-substituted or unsubstituted phenylketones |
GB1468111A (en) * | 1976-01-08 | 1977-03-23 | Pfizer Ltd | Thiophene-sulphonamides |
US4226783A (en) * | 1978-07-03 | 1980-10-07 | E. I. Du Pont De Nemours And Company | α-Chlorination process |
US4406896A (en) * | 1979-12-20 | 1983-09-27 | Merck & Co., Inc. | Adjuvants for rectal delivery of drug substances |
NZ196348A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered antibiotics |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
JPS5967246A (ja) * | 1982-09-10 | 1984-04-16 | ザ・ウエルカム・フアウンデ−シヨン・リミテツド | 置換ビフエニル化合物 |
FR2617476B1 (fr) * | 1987-07-03 | 1989-11-17 | Oreal | Nouveaux derives polycycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique |
DK77393D0 (da) * | 1993-06-29 | 1993-06-29 | Novo Nordisk As | Aktivering af enzymer |
EP0711157A4 (en) * | 1993-08-06 | 1996-07-31 | Smithkline Beecham Corp | ENDOTHELIN RECEPTOR ANTAGONISTS |
US5491140A (en) * | 1994-06-30 | 1996-02-13 | Eli Lilly And Company | Naphthyl tachykinin receptor antagonists to treat physiological conditions |
US5538991A (en) * | 1994-09-14 | 1996-07-23 | Merck & Co., Inc. | Endothelin antagonists bearing 5-membered heterocyclic amides |
US7501441B1 (en) * | 1994-09-20 | 2009-03-10 | Eli Lilly And Company | Naphthyl compounds, intermediates, processes, compositions, and methods |
WO1996018616A1 (en) * | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
WO1996018617A1 (en) * | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
DE59603311D1 (de) * | 1995-01-30 | 1999-11-18 | Hoechst Ag | Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
US6391892B1 (en) * | 1995-03-10 | 2002-05-21 | Eli Lilly And Company | Naphthyl pharmaceutical compounds |
US6451817B1 (en) * | 1995-03-10 | 2002-09-17 | Eli Lilly And Company | Alpha-substituted-1-benzyl-napthyls |
-
1998
- 1998-01-20 PA PA19988444901A patent/PA8444901A1/es unknown
- 1998-01-20 IT IT98MI000090A patent/IT1298159B1/it active IP Right Grant
- 1998-01-21 RU RU99118507/04A patent/RU2188192C2/ru active
- 1998-01-21 ZA ZA98495A patent/ZA98495B/xx unknown
- 1998-01-21 BR BR9807520A patent/BR9807520A/pt not_active IP Right Cessation
- 1998-01-21 IL IL13090998A patent/IL130909A0/xx unknown
- 1998-01-21 DE DE69805974T patent/DE69805974T2/de not_active Expired - Fee Related
- 1998-01-21 ES ES98905325T patent/ES2178162T3/es not_active Expired - Lifetime
- 1998-01-21 PL PL98334769A patent/PL334769A1/xx unknown
- 1998-01-21 DK DK98905325T patent/DK0966437T3/da active
- 1998-01-21 JP JP53156898A patent/JP3607706B2/ja not_active Expired - Fee Related
- 1998-01-21 EP EP98905325A patent/EP0966437B1/en not_active Expired - Lifetime
- 1998-01-21 PT PT98905325T patent/PT966437E/pt unknown
- 1998-01-21 WO PCT/EP1998/000306 patent/WO1998032732A1/en not_active Application Discontinuation
- 1998-01-21 CN CNB988021153A patent/CN1159293C/zh not_active Expired - Fee Related
- 1998-01-21 HU HU0001061A patent/HUP0001061A3/hu unknown
- 1998-01-21 YU YU34499A patent/YU34499A/sh unknown
- 1998-01-21 CA CA002278687A patent/CA2278687C/en not_active Expired - Fee Related
- 1998-01-21 CZ CZ992593A patent/CZ259399A3/cs unknown
- 1998-01-21 NZ NZ336684A patent/NZ336684A/en unknown
- 1998-01-21 ID IDW990768A patent/ID22825A/id unknown
- 1998-01-21 AT AT98905325T patent/ATE219051T1/de not_active IP Right Cessation
- 1998-01-21 TR TR1999/01783T patent/TR199901783T2/xx unknown
- 1998-01-21 AU AU60956/98A patent/AU721407B2/en not_active Ceased
- 1998-01-23 PE PE1998000049A patent/PE51499A1/es not_active Application Discontinuation
- 1998-01-26 US US09/013,328 patent/US5962531A/en not_active Expired - Fee Related
- 1998-01-26 AR ARP980100325A patent/AR011571A1/es unknown
- 1998-01-26 TN TNTNSN98013A patent/TNSN98013A1/fr unknown
- 1998-01-26 FR FR9800779A patent/FR2758818B1/fr not_active Expired - Fee Related
- 1998-01-26 CO CO98003314A patent/CO4930273A1/es unknown
- 1998-01-26 TW TW087101125A patent/TW520355B/zh active
- 1998-01-27 DE DE19803003A patent/DE19803003A1/de not_active Withdrawn
- 1998-01-27 SV SV1998000013A patent/SV1998000013A/es not_active Application Discontinuation
- 1998-01-27 ES ES009800141A patent/ES2135351B1/es not_active Expired - Fee Related
- 1998-01-27 GB GB9801711A patent/GB2321457B/en not_active Expired - Fee Related
- 1998-01-27 UY UY24860A patent/UY24860A1/es unknown
- 1998-01-28 HR HR60/036,466A patent/HRP980046A2/hr not_active Application Discontinuation
- 1998-01-28 MA MA24949A patent/MA26469A1/fr unknown
-
1999
- 1999-06-21 US US09/337,695 patent/US6150397A/en not_active Expired - Fee Related
- 1999-07-26 KR KR1019997006731A patent/KR100313180B1/ko not_active IP Right Cessation
- 1999-07-27 NO NO19993633A patent/NO313136B1/no not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH384567A (de) * | 1958-10-17 | 1964-11-30 | Geigy Ag J R | Verfahren zur Herstellung neuer Benzophenonsulfonamide |
US3899529A (en) * | 1973-02-22 | 1975-08-12 | Merck & Co Inc | Aroyl substituted naphthalene acetic acids |
EP0354329A1 (de) * | 1988-07-09 | 1990-02-14 | Bayer Ag | (Hetero)Aryloxynaphthaline mit über Schwefel gebundenen Substituenten |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204746A (es) | Nuevos derivados de tiazolilbenzofuranos, procedimientos para la preparacion de los mismos y las composiciones farmaceuticas que los contienen. | |
EP1070710A3 (en) | Dithiolan derivatives, their preparation and their therapeutic effect | |
TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
HK1039126A1 (en) | Quinazoline derivatives. | |
IL108602A0 (en) | N-alkyl-2-substituted atp analogues, their preparation and pharmaceutical compositions containing them | |
ES2141137T3 (es) | Agentes terapeuticos para la enfermedad de parkinson. | |
ATE250623T1 (de) | 4'-c-ethynyl-purin-nukleoside | |
ES2135351A1 (es) | Derivados de 5-aroilnaftaleno. | |
ATE57919T1 (de) | Triazinderivate, verfahren zur herstellung der derivate und die derivate als wirksamen bestandteil enthaltende herbizide. | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
ATE81655T1 (de) | Cephemverbindungen und verfahren zu ihrer herstellung. | |
EP0183848A4 (en) | POLYACAHETEROCYCLIC COMBINATING UNITS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL COMPOSITION. | |
CA2014521A1 (en) | 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them | |
RU99115829A (ru) | Новые аналоги камптотецина, их применение в качестве лекарственных средств и содержащие их фармацевтические композиции | |
WO2001044207A8 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant | |
ZA9811645B (en) | Acronycine compounds a process for their preparation and pharmaceutical compositions containing them | |
DE60144246D1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren verwendung | |
ATE497497T1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung | |
IL149620A0 (en) | 5-D-β-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE | |
WO2000024389A3 (en) | Benzoquinoline derivatives useful as antibacterial agents | |
PL367073A1 (en) | Dihydroimidazo [5,1-a]-$g(b)-carboline derivatives, method for preparing same and use thereof as medicine | |
BR0201312A (pt) | Compostos de pirimidin-4-ona, processo para sua preparação e composições farmacêuticas contendo os referidos | |
WO2001081315A3 (en) | Amino-imidazole derivatives for treating cancer | |
ATE233266T1 (de) | 8h-(2,3-b)-pyrrolozin-8-one derivate, verfahren zur ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
DE60111653D1 (de) | Aminoflavonverbindungen, zusammensetzungen und ihre verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19991016 Kind code of ref document: A1 Effective date: 19991016 |
|
FD1A | Patent lapsed |
Effective date: 20040916 |